nicotine addiction | GenomeWeb

nicotine addiction

NEW YORK (GenomeWeb News) – Bioinformatics and data analysis firm BioRealm said on Wednesday it has received a Small Business Innovation Research contract from the National Institute on Drug Abuse to develop a genetic screening tool for tobacco addiction and treatment approaches.

A team led by researchers at Washington University in St. Louis has shown that genetic variants associated with nicotine dependence and smoking quantity are also predictive of whether patients will benefit from the use of smoking cessation medications.

The company has won an SBIR grant from NIDA to develop a systems biology database and analysis tool for nicotine addiction.

With this new funding, the NIH hopes to continue PGx research in existing focus areas of cancer, heart disease, asthma, and nicotine addiction, and also to expand into new areas, including rheumatoid arthritis and bipolar disorder.

An ever-increasing number of studies are looking at the role that genetics and epigenetics play in the predisposition for — and treatment of — alcohol abuse, nicotine dependence, and drug addiction.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.